Marché mondial du traitement de la cysticercose – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et taille du marché du traitement de la cysticercose

Le marché mondial du traitement de la cysticercose devrait connaître une croissance significative au cours de la période de prévision. La fréquence maximale des infections est principalement causée par la variété de ténias Taenia solium que l'on trouve principalement dans le porc. L'augmentation de l'adoption du traitement de la cysticercose et l'évolution des économies telles que la Chine, l'Inde et d'autres créeront de nouvelles opportunités pour le marché mondial du traitement de la cysticercose. Le COVID-19 a également eu un impact majeur sur la croissance du marché.

Data Bridge Market Research analyse le taux de croissance du marché mondial du traitement de la cysticercose au cours de la période de prévision 2022-2029. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe Data Bridge Market Research comprend également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Définition du marché

La cysticercose, également connue sous le nom d'infection par le ténia du porc, est définie comme une infection protozoaire principalement causée par des kystes larvaires du ténia taenia solium affectant le cerveau, les muscles et d'autres tissus. Elle se transmet principalement par contact fermé avec des mains sales, des aliments contaminés, des liquides, des maux de tête soudains et des bosses sous la peau. Elle revêt une grande importance pour le secteur de la santé et devrait donc augmenter fortement au cours de la période de prévision.

Portée et segmentation du marché du traitement de la cysticercose

Global Cysticercosis Treatment Market Dynamics

Drivers

• Rising Incidence of Parasitic Infection

According to the International Journal of Surgery records, Neurocysticercosis (NCC) is the most common parasitic infestation of the brain, and it is projected that almost 50 million people worldwide suffer from this disease. About, 50,000 individuals with Neurocysticercosis die each year because of the disease. Thus, this boosts the market growth.

Opportunities

• Rise in adoption of cysticercosis treatment

Increase in adoption of cysticercosis treatment in developing economies such as China and India is anticipated to offer substantial opportunities for the global cysticercosis treatment market.

• Increase in Protozoan Infections

Increase in the cases of protozoan infections globally and a lack of sanitation practices in some of the developing countries are projected to boost the cysticercosis treatment market during the forecast period. Thus, it creates an opportunity for the market growth.

Restraints/Challenges

• Complications of cysticercosis

The disease's major complications mainly include brain edema, chronic meningitis, vasculitis, paralysis, hydrocephalus, coma, partial blindness, seizures, and death. This acts as a major hindrance in the market growth.

•        Higher cost of research & development

Higher cost of research & development and increasing frequency of severe reactions, due to the body’s inflammatory reaction to the dying parasites, are major factors limiting the global cysticercosis treatment market.

This global cysticercosis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cysticercosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cysticercosis Treatment Market Scope

The global cysticercosis treatment market is segmented on the basis of drug, drug class, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Antiparasitic therapy
• Albendazole
• Corticosteroids
• Dexamethasone
• Prednisone
• Antiepileptic drugs
• Praziquantel
• Albendazole
• Surgery

Drug Type

• Branded
• Generic

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Cysticercosis Treatment Market Regional Analysis/Insights

The global cysticercosis treatment market is analysed and market size insights and trends are provided by drug, drug class, distribution channel and end-user as referenced above.

The major countries covered in the global cysticercosis treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the high diagnostic rate and presence of sophisticated medical facilities to maximize the treatment effectiveness for patient and increase focuses in the research and development activity.

Asia-Pacific dominates the market due to the growing cases of protozoan infections, developing healthcare facilities and presence of generic companies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Cysticercosis Treatment Market Share Analysis

The global cysticercosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global cysticercosis treatment market.

Les principaux acteurs opérant sur le marché mondial du traitement de la cysticercose comprennent :

• Pfizer Inc (États-Unis)
• F. Hoffmann-La Roche SA (Suisse)
• Mylan NV (États-Unis)
• Fresenius Kabi AG (Allemagne)
• Novartis SA (Suisse)
• Teva Pharmaceutical Industries Ltd. (Israël)
• Société Bristol Myers Squibb (États-Unis)
• GSK Plc. (Royaume-Uni)
• Bayer AG (Allemagne)
• Strides Pharma Science Limited (Inde)

SKU-54106